Advanced company searchLink opens in new window

PEBBLE BIOTECHNOLOGY LABORATORIES LTD

Company number 11278041

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Apr 2024 CS01 Confirmation statement made on 26 March 2024 with no updates
04 Mar 2024 AP01 Appointment of Mr Richard Henry Smith as a director on 4 March 2024
21 Dec 2023 AA Total exemption full accounts made up to 31 March 2023
16 Aug 2023 AD01 Registered office address changed from 3F8 Building 3 Alderley Park Macclesfield SK10 4TG England to 122, Beech Court Hollin Lane Styal Wilmslow SK9 4LD on 16 August 2023
19 Apr 2023 CS01 Confirmation statement made on 26 March 2023 with updates
23 Dec 2022 AA Total exemption full accounts made up to 31 March 2022
04 Nov 2022 MA Memorandum and Articles of Association
04 Nov 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Name change to peblle biotechnology laboratories LTD 01/11/2022
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Nov 2022 CERTNM Company name changed perfusion biotechnology LTD\certificate issued on 03/11/22
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2022-11-01
02 Nov 2022 AP01 Appointment of Dr Anthony Flinn as a director on 1 November 2022
02 Nov 2022 SH01 Statement of capital following an allotment of shares on 1 November 2022
  • GBP 21.181
22 Aug 2022 AD01 Registered office address changed from 3F66 Building 3 Alderley Park Macclesfield SK10 4TG England to 3F8 Building 3 Alderley Park Macclesfield SK10 4TG on 22 August 2022
29 Apr 2022 CS01 Confirmation statement made on 26 March 2022 with updates
30 Dec 2021 AA Total exemption full accounts made up to 31 March 2021
04 Aug 2021 CH01 Director's details changed for Dr James Edward Fildes on 22 July 2021
04 Aug 2021 AP01 Appointment of Mr Mark Roy Claydon as a director on 22 July 2021
04 Aug 2021 AP01 Appointment of Mr Douglas Colin Walter Stellman as a director on 22 July 2021
15 Jul 2021 PSC04 Change of details for Dr James Edward Fildes as a person with significant control on 29 June 2021
14 Jul 2021 SH08 Change of share class name or designation
13 Jul 2021 SH01 Statement of capital following an allotment of shares on 29 June 2021
  • GBP 20.96
13 Jul 2021 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES13 ‐ Sub division 29/06/2021
  • RES01 ‐ Resolution of adoption of Articles of Association
13 Jul 2021 MA Memorandum and Articles of Association
12 Jul 2021 SH02 Sub-division of shares on 29 June 2021
09 Jul 2021 AD01 Registered office address changed from 38 Carrwood Knutsford Cheshire WA16 8NE England to 3F66 Building 3 Alderley Park Macclesfield SK10 4TG on 9 July 2021
24 Jun 2021 CH01 Director's details changed for Dr James Edward Fildes on 21 June 2021